Riverbridge Partners’s Definitive Healthcare DH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-1,756,726
Closed -$14.2M 181
2024
Q1
$14.2M Sell
1,756,726
-5,847
-0.3% -$51.7K 0.17% 86
2023
Q4
$17.5M Sell
1,762,573
-1,054,444
-37% -$8.28M 0.22% 86
2023
Q3
$22.5M Sell
2,817,017
-79,874
-3% -$802K 0.31% 82
2023
Q2
$31.9M Buy
2,896,891
+76,043
+3% +$783K 0.4% 74
2023
Q1
$29.1M Sell
2,820,848
-26,533
-0.9% -$312K 0.41% 75
2022
Q4
$31.3M Buy
2,847,381
+433,758
+18% +$5.58M 0.47% 73
2022
Q3
$37.5M Buy
2,413,623
+169,842
+8% +$3.74M 0.56% 65
2022
Q2
$51.5M Buy
+2,243,781
New +$48M 0.82% 45

Other funds holding DH

Riverbridge Partners's DH Position: Q2 2024 in Review

Riverbridge Partners sold out of Definitive Healthcare (DH) in Q2 2024, closing a stake of 1,756,726 shares — an estimated $14.2M sold.

Riverbridge Partners first reported a position in DH in Q2 2022 and held it in 8 quarters. The position peaked at $51.5M in Q2 2022. 144 funds tracked by Wall St. Rank hold DH as of Q2 2024.

  • Riverbridge Partners reported no remaining Definitive Healthcare position as of Q2 2024 after selling out during the quarter.
  • Riverbridge Partners sold 1,756,726 Definitive Healthcare shares in Q2 2024, an estimated $14.2M.
  • Riverbridge Partners first reported a position in Definitive Healthcare in Q2 2022 and held it in 8 quarters.
  • Riverbridge Partners's Definitive Healthcare position peaked at $51.5M in Q2 2022.
  • 144 funds tracked by Wall St. Rank held Definitive Healthcare as of Q2 2024.

Based on Riverbridge Partners's 13F filing for Q2 2024, filed 17 Jul 2024.